banner
JAK inhibitor Tofacitinib, Purity ≥98%
Inquiry

Cat. No.: X23-10-ZQ424

JAK inhibitor Tofacitinib, Purity ≥98%

Synonym: Tofacitinib; 477600-75-2; Tasocitinib; 3-((3R,4R)-4-Methyl-3-(methyl(7S-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile; JAK inhibitor

  • MDL: MFCD11035919
  • CAS Number: 477600-75-2
  • Compound CID: 9926791
img
Product Size
50 mg; 100 mg; 250 mg; 500 mg
Price
Datasheet
MSDS
Properties
Description
Tofacitinib, soluble in warmed DMSO and insoluble in water and ethanol, is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK1, JAK2, JAK3, Lck, and Rock-II.
Molecular Weight
312.37
Molecular Formula
C16H20N6O
Targets
JAK1: 112 nM; JAK2: 20 nM; JAK3: 1 nM; Lck: 3870 nM; Rock-II: 3400 nM
Form
Lyophilized powder
Purity
≥98%
Solubility
Warmed DMSO: 56 mg/mL (179.27 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Applications
Tofacitinib can be used to investigate its JAK1/3 inhibition for research in rheumatoid arthritis and other inflammatory diseases.
Publications
Publications (0)

Publications

×
Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.

  • You can upload up to 5 images or ZIP files, and the size of a single file may not exceed 5MB.
Related Products
Quick Links

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0